Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix has been awarded three new R01 grants from the National Institutes of Health (NIH), the gold standard of federally funded research awards. The NIH grants total close to $9 million and will support groundbreaking research to develop targeted treatments for pediatric lung diseases and improve surgical outcomes for children with spinal abnormalities. These grants further position the Phoenix Children’s Research Institute as a national leader in pediatric research, driving innovations that shape the future of children’s health.
Internationally renowned researcher and director of the Phoenix Children’s Research Institute, Vlad Kalinichenko, MD, PhD received two NIH grants, with total funding of $6 million to advance the understanding and treatment of severe pediatric lung diseases, bronchopulmonary dysplasia (BPD) and Alveolar Capillary Dysplasia with misalignment of pulmonary vein (ACDMPV).
“Both grants focus on developing new technologies and therapies that could prevent severe lung diseases later in life, not just treat symptoms in childhood,” said Dr. Kalinichenko. “This work has the potential to transform public health, reduce healthcare costs and improve outcomes for both pediatric and adult patients with lung diseases.”…